Filter
2539
Filtered Results: 2539
Text search:
Vaccine
safety
Featured
Recommendations
309
New Publications
658
Language
Document type
No document type
1125
Guidelines
454
Studies & Reports
406
Manuals
157
Strategic & Response Plan
153
Fact sheets
113
Situation Updates
41
Training Material
39
Resource Platforms
13
Videos
13
Brochures
9
Infographics
8
Online Courses
7
App
1
Countries / Regions
Global
107
India
81
Kenya
79
Sierra Leone
65
Liberia
65
Nigeria
63
South Africa
57
Latin America and the Carribbean
53
Uganda
48
Africa
47
Ethiopia
45
Western and Central Europe
42
Ghana
37
Congo, Democratic Republic of
35
Zambia
35
Tanzania
32
Nepal
31
Philippines
27
Bangladesh
27
Syria
26
West and Central Africa
26
Malawi
25
Brazil
25
Ukraine
25
Myanmar / Burma
25
Rwanda
24
East and Southern Africa
23
South Sudan
21
Middle East and North Africa
21
Guinea
20
South–East Asia Region
19
Russia
19
Zimbabwe
16
Pakistan
15
Namibia
15
Yemen
15
Germany
13
Eastern Europe and Central Asia
13
Senegal
12
Haiti
11
Mozambique
11
Lesotho
11
Sudan
10
Botswana
10
Cambodia
9
Indonesia
9
Central African Republic
9
Western Pacific Region
9
Eastern Europe
9
Burkina Faso
8
USA
7
Cameroon
7
Lebanon
7
Venezuela
7
Somalia
6
Afghanistan
6
China
6
Asia
6
Vietnam
6
Mali
5
Jordan
5
Argentina
5
Eswatini/ Swaziland
5
Colombia
5
Ecuador
5
Madagascar
5
Chile
5
Paraguay
5
Laos
5
Niger
4
Iraq
4
Turkey
4
Bolivia
4
Côte d’Ivoire / Ivory Coast
3
Saudi Arabia
3
Egypt
3
Chad
3
Thailand
3
Peru
3
El Salvador
3
Libya
3
Palestine
3
Albania
3
Moldova
3
United Kingdom
3
Spain
3
Guinea-Bissau
2
Morocco
2
Papua New Guinea
2
Benin
2
North Macedonia
2
Burundi
2
Nicaragua
2
Sri Lanka
2
Fiji
2
Timor Leste/ East Timor
2
Qatar
2
Iran
2
France
2
Tunisia
2
Togo
1
Gambia
1
Malaysia
1
Mauritania
1
Dominican Republic
1
Cuba
1
Honduras
1
Angola
1
Guatemala
1
Mexico
1
Bhutan
1
Djibouti
1
Southern Africa
1
Congo-Brazzaville
1
Tajikistan
1
Bulgaria
1
Kazakhstan
1
Georgia
1
North America
1
Gabon
1
Jamaica
1
Japan
1
Denmark
1
Maldives
1
Mauritius
1
Portugal
1
South Korea
1
Belarus
1
French Guyana
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
936
Clinical Guidelines
232
Public Health
133
Women & Child Health
127
Key Resources
118
Pharmacy & Technologies
42
Capacity Building
30
Toolboxes
COVID-19
537
Rapid Response
140
Ebola
135
AMR
135
HIV
110
TB
101
Pharmacy
92
Conflict
66
Planetary Health
61
Global Health Education
55
Caregiver
50
Refugee
45
NTDs
45
Polio
32
Natural Hazards
30
Cholera
29
Zika
27
Mental Health
27
Health Financing Toolbox
22
Disability
13
NCDs
11
Specific Hazards
10
South Sudan
1
1 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring ... and equitable access – in WHO’s Vaccines Explained series.
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strateg...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An ...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major bar...
Child and adolescent vaccine safety report
This report on the safety of COVID-19 vaccination in children and adolescents in Argentina includes dat...
Position paper on vaccination with Sputnik V vaccine | National Commission on Vaccine Safety (CoNaSeVa) | 12 May 2021
Many vaccines and drugs hold the promise of reducing mortality and morbidity among pregnant women and infants living in low- and middle-income countries (LMICs). However, sufficient information on the safe... of drugs and vaccines in pregnant women is rarely available at the time of product licensure or approval. To account for this, active safety surveillance efforts are needed during the post-licensure and post-approval
phase to assess the safety of drugs and vaccines in pregnant women and their offspring. Pregnancy exposure registries (PER) are used to monitor the safety of vaccines and drugs. PERs are observational studies that systematically collect health information on exposure to medical products such as drugs and vaccines during pregnancy. This review demonstrates that a number of resources presently exist in LMICs that perform active safety surveillance in pregnant populations. These results indicate such systems employ a wide variety of approaches, each with their own set of strengths and challenges, as summarized in the final section of the report.
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety...
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated ... is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) high containment facility.
The vaccine received DCGI approval for Phase I & II Human Clinical Trials and the trials commenced across India from July, 2020.
After successful completion of the interim analysis from the Phase 1 & 2 clinical trials of COVAXINTM, Bharat Biotech received DCGI approval for Phase 3 clinical trials in 26,000 participants in over 25 centres across India.
Tackling COVID-19 misinformation. Ensuring communities have access to lifesaving public health information from trusted sources and are not misled by misinformation is essential to ending the COVID-19 pandemic.
In an effort to empower doctors and nurses – some of the most effective and trusted...
WHO PQS Devices Catalogue. Pre-qualified equipment for the Expanded Programme on Immunization (EPI)
recommended
The PQS on-line catalogue includes details of all immunization-related products currently pre-qualified by WHO for procurement by United Nations agencies. The catalogue is produced and maintained by the Quality, Safety and Standards group in the Imm...
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendation...
Interim guidance. 12 May 2021. The Continuity of essential health services: Facility Assessment Tool can be used by countries to rapidly assess the capacity of health facilities to maintain the provision of essential health services during the COVID-19 pandemic. It can help to alert the authorities ...
1.0 PURPOSE
To define the procedure for the conduct of in-person meetings in both healthcare and community settings in response to COVID-19 and with respect to Public Health and Social Measures (PHSMs) to reduce the risk of disease transmission. A general risk assessment must be conducted to inform...
Dengue is the fastest spreading, mosquito-borne viral infectious disease worldwide, with remarkable morbidity and mortality. In the past decades, profound contributions have been made towards understanding its epidemiology, including disease burden and distributions, risk factors, and control and pr...
This dataset contains data from WHO's data portal covering the following categories:
Air pollution, Antimicrobial resistance (AMR), Assistive technology, Child mortality, Dementia diagnosis, treatment and care, Dementia policy and legislation, Environment and health, Foodborne Diseases Estimates,...
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environ...
The arrival of safe, effective COVID-19 vaccines is a major development in the coronavirus pandemic. An effective COVID-19 vaccine will help protect people who come in contact with the virus from be...
The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of the Rt. Hon. Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the...
If you have been wondering when you would receive your vaccine? Why you should get vaccinated and are concerned about what your are hearing about side effects, this episode of Science with 5 with WHO’s Chief Scientist Dr Soumya Swaminathan is for ...
